Context

Bansk Group completed the acquisition of 100% of PetIQ in an all-cash public-to-private transaction. PetIQ was delisted from Nasdaq upon closing and is now operated as a privately held company, with founder Cord Christensen continuing as CEO. The existing executive management team will continue to operate the business independently. The strategic rationale centres on accelerating PetIQ's mission of providing convenient and affordable pet healthcare, investing in marketing and innovation, and pursuing strategic bolt-on acquisitions — initiatives that Bansk believes are better executed outside the constraints of public market ownership.

Target

PetIQ is a leading US-based pet medication, health and wellness company, operating across two complementary business segments: (1) a product division, which develops, manufactures, and distributes branded and third-party pet medications as well as health and wellness items through retail and e-commerce channels, with world-class manufacturing facilities located in Omaha (Nebraska), Springville (Utah), and Daytona Beach (Florida); and (2) a veterinary services division, which operates over 2,600 mobile community clinic locations and wellness centers hosted at retail partner locations across 39 US states, providing convenient and affordable access to veterinary care for pet owners.